27 results
DEFM14A
TRHC
Tabula Rasa HealthCare, Inc.
29 Sep 23
Proxy related to merger
5:03pm
weaknesses” (as defined by the Public Company Accounting Oversight Board) in the design or operation of the Company’s internal controls over financial
PREM14A
TRHC
Tabula Rasa HealthCare, Inc.
18 Sep 23
Preliminary proxy related to merger
5:15pm
identified or been made aware of (i) “significant deficiencies” or “material weaknesses” (as defined by the Public Company Accounting Oversight Board
DEFA14A
EX-2.1
TRHC
Tabula Rasa HealthCare, Inc.
7 Aug 23
Additional proxy soliciting materials
7:33am
Oversight Board) in the design or operation of the Company’s internal controls over financial reporting which would reasonably be expected to adversely
8-K
EX-2.1
TRHC
Tabula Rasa HealthCare, Inc.
7 Aug 23
Entry into a Material Definitive Agreement
7:08am
Oversight Board) in the design or operation of the Company’s internal controls over financial reporting which would reasonably be expected to adversely
8-K
EX-99.1
TRHC
Tabula Rasa HealthCare, Inc.
17 May 23
Regulation FD Disclosure
8:05am
adherence packaging, and clinical oversight for complex patients ◼ Revenue Model: Per script (e.g., AWP-%) + dispensing fee + PMPM TPA Services ◼ Claims … ✓ Unmatched clinical oversight and support of geriatric-certified PharmD ✓ Data-driven, clinically validated prospective medication safety analysis
PRE 14A
etev2nif9szsyctsb1bk
13 Apr 23
Preliminary proxy
5:01pm
8-K
EX-10.1
tb0k22fk4z
14 Sep 22
Tabula Rasa HealthCare Announces Cooperation Agreement with Indaba Capital Management to Refresh the Company’s Leadership and Board of Directors
8:18am
8-K
EX-99.1
ob5fyh4 nhsv5
5 Oct 20
Tabula Rasa HealthCare Expands CareVention HealthCare Offerings with the Addition of PersonifilRx and Pharmastar
7:30am